3rd Quarter - Report

ARDELYX, INC. for ARDELYX, INC.

Firm
Client
Income
—
Expenses
$650,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Access to innovative kidney treatments. H.R.5074 - Protecting Young Minds Online Act, S.4510 - Kidney PATIENT Act of 2024. Pharmaceutical pricing proposals, Medicare pharmaceutical payment and access issues. Coverage of oral only End-Stage Renal Disease drugs.

LobbyistCovered position, as disclosed
THERESA JOLIVETTE —
ZACHARY KRIBS —
MATTHEW LASH —
PAUL PEREIRA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 4510 (119th), H.R. 5074 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.